trial · primary record
Toripalimab
Nasopharyngeal Carcinoma (NPC)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2029-12-31 |
| Primary endpoint | 2-year progression free survival period |
| Registry ID | NCT07136519 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:27.988Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07136519
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.